Rockwell Medical Inc. has promoted Tim Chole to chief commercial officer, reporting to President/CEO Mark Strobeck, Ph.D.
"Tim has an exceptional track record successfully building renal care portfolios and significantly growing sales at some of the largest renal care companies in the world," Dr. Strobeck said. "Tim has played a key role in helping us increase our market share, broaden our product portfolio, right-size our pricing, improve our gross margins, and achieve record net sales quarter-over-quarter and year-over-year. I am thrilled to be working alongside Tim at this key juncture in Rockwell's history as we aim to continue to grow our business through organic and inorganic growth and other business development opportunities that support our strategic objectives."
Chole joined Rockwell Medical in December 2019 as senior vice president of Sales and Marketing. In November 2022, following the company's new business strategy announcement, Chole led Rockwell's commercial organization and supported the vision to focus its efforts on enhancing its revenue-generating businesses and pursuing profitability.
"Customers want to work with Rockwell because we are dedicated to providing the highest quality products supported by the best customer service in the industry," Chole stated. "I am excited by the progress that we have made and the opportunities that lie ahead for Rockwell. It is a privilege to help steward the commercial future of this organization as we strive to positively impact more vulnerable patients with end-stage kidney disease."
Chole has more than 20 years' experience in commercial leadership roles for pharmaceutical and medical device companies. He has a track record of success launching products and growing mature portfolios, many of which have been therapeutics or devices for renal disease treatment. Early in his career, Chole was the marketing lead for the IV iron portfolio at Watson Pharmaceuticals (now Allergan), and later was the global marketing director for AKI Therapy at Gambro AB (now Baxter International). Chole's background includes global and U.S. marketing leadership and market development roles. Before joining Rockwell Medical, Chole served as the director of Product Marketing and Professional Education for hearing implants at Cochlear Americas.
Chole earned a bachelor of science degree in managerial economics from the University of California at Davis.
Rockwell Medical Inc. develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease. Rockwell Medical is the largest supplier of liquid bicarbonate concentrates and the second largest supplier of acid and dry bicarbonate concentrates for dialysis patients in the United States.